Subject(s)
Anti-Bacterial Agents/administration & dosage , Antibiotic Prophylaxis/standards , Digestive System Surgical Procedures/standards , Endovascular Procedures/standards , Radiography, Interventional/standards , Vascular Surgical Procedures/standards , Adult , Drug Administration Schedule , Drug Resistance, Bacterial , Evidence-Based Medicine , Humans , Societies, Medical/standards , Terminology as TopicSubject(s)
Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/standards , Endovascular Procedures/standards , Blood Vessel Prosthesis Implantation/adverse effects , Contraindications , Endovascular Procedures/adverse effects , Evidence-Based Medicine , Humans , Patient Selection , Postoperative Care/standards , Reoperation , Societies, Medical/standards , Terminology as Topic , Treatment OutcomeABSTRACT
PURPOSE: To quantify the influence of angiography table height on patient and angiographer irradiation, as compared with other routine protective measures such as the use of protective shields hanging at the tableside and from the ceiling of angiography suites. METHODS: An experimental study was carried out in which a phantom (substitute for a human body) placed on the angiography table was irradiated by pulsed fluoroscopy. Entrance exposure rates were measured at the phantom surface (surrogate of patient skin exposure by incident X-ray beam) and at 60 cm from the phantom (analog to angiographer skin exposure by scatter). Exposure rates were measured at levels corresponding to the knees, testes, waist, xyphoid appendix, shoulders, and eyes of an angiographer 178 cm tall. Measurements were repeated at angiography table heights of 85, 95, 105, and 110 cm from the floor, with and without protective shields. RESULTS: Moving the table from its highest to lowest position increased by 32% the phantom entrance exposure but decreased scatter to the angiographer. Scatter to the angiographer could be reduced most by using the protective shields (30-105 times less), but low table heights provided relatively more important protection (412-1121 muSv/hr reduction, or 15-72% scatter reduction) when shields were not used (e.g., for unprotected regions of the angiographer's body such as the hands). CONCLUSION: Working at lower table heights provides a little additional protection to exposed body parts of angiographers, at the cost of somewhat higher patient exposure. Although small, this incremental protection could be clinically relevant in the long term. The choice of table position should be a compromise based on multiple factors, including at least patient exposure, scatter to angiographers, and angiographer comfort.
Subject(s)
Angiography/instrumentation , Fluoroscopy/adverse effects , Phantoms, Imaging , Radiation Injuries/prevention & control , Radiation Protection/instrumentation , Equipment Design , Fluoroscopy/instrumentation , Humans , Radiometry/instrumentation , Scattering, RadiationABSTRACT
PURPOSE: To assess outcomes after microcoil embolization for active lower gastrointestinal (GI) bleeding. METHODS: We retrospectively studied all consecutive patients in whom microcoil embolization was attempted to treat acute lower GI bleeding over 88 months. Baseline, procedural, and outcome parameters were recorded following current Society of Interventional Radiology guidelines. Outcomes included technical success, clinical success (rebleeding within 30 days), delayed rebleeding (>30 days), and major and minor complication rates. Follow-up consisted of clinical, endoscopic, and pathologic data. RESULTS: Nineteen patients (13 men, 6 women; mean age +/- 95% confidence interval = 70 +/- 6 years) requiring blood transfusion (10 +/- 3 units) had angiography-proven bleeding distal to the marginal artery. Main comorbidities were malignancy (42%), coagulopathy (28%), and renal failure (26%). Bleeding was located in the small bowel (n = 5), colon (n = 13) or rectum (n = 1). Technical success was obtained in 17 patients (89%); 2 patients could not be embolized due to vessel tortuosity and stenoses. Clinical follow-up length was 145 +/- 75 days. Clinical success was complete in 13 (68%), partial in 3 (16%), and failed in 2 patients (11%). Delayed rebleeding (3 patients, 27%) was always due to a different lesion in another bowel segment (0 late rebleeding in embolized area). Two patients experienced colonic ischemia (11%) and underwent uneventful colectomy. Two minor complications were noted. CONCLUSION: Microcoil embolization for active lower GI bleeding is safe and effective in most patients, with high technical and clinical success rates, no procedure-related mortality, and a low risk of bowel ischemia and late rebleeding.